The world's first flight test for an aerospike rocket engine ended in disaster, but Polaris Aerospace is back on track, preparing to fly two new prototypes for its MIRA supersonic/hypersonic ...

Choose options to include in this vehicle value. (*)Includes the value of the outboard motor(s). Only select options that are in addition to standard equipment and equipment noted in the manufacturer ...

Mira is looking to change that. Mira is an at-home, palm-sized hormone testing device women use to test their urine for their hormone levels. Mira’s corresponding app deciphers their results and ...

India has 29 states with at least 720 districts comprising of approximately 6 lakh villages, and over 8200 cities and towns. Indian postal department has allotted a unique postal code of pin code ...

Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic pain MIAMI, FL / ACCESSWIRE / September 27, 2024 / MIRA Pharmaceuticals ...

OpenAI’s executive exodus is continuing with three top leaders announcing their exits Wednesday, including Chief Technology Officer Mira Murati. Murati — who has been instrumental in the ...

It’s been a tumultuous 12 months for Mira Murati, one of the driving forces behind OpenAI’s meteoric rise. As the company’s chief technology officer, Murati worked behind the scenes to guide ...

OpenAI’s CTO Mira Murati posted on X on Wednesday saying she is leaving the company. Murati said she is stepping away to do her own exploration after more than six years at the AI startup.

In a recent interview at Cannes Lions 2024, a gathering for creative and communications professionals, OpenAI's CTO Mira Murati said her mother's first question to ChatGPT was: "When will Mira get ...

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing On Early Clinical Efficacy Demonstration For Neuropathic Pain In 2025 Sponsored Telomir ...

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog ...